Lysine-independent ubiquitination of Epstein-Barr virus LMP2A

Virology

Volumn 300, Issue 1, 2002, Pages 153-159

  Ikeda, Masato ^a   Ikeda, Akiko ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2A; LYSINE; MEMBRANE PROTEIN; MUTANT PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL LINE; EPSTEIN BARR VIRUS; MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN TARGETING;

HUMAN HERPESVIRUS 4;

EID: 0036382917     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1562     Document Type: Article

References (31)

1. Aviel, S., Winberg, G., Massucci, M., and Ciechanover, A. (2000). Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue. J. Biol. Chem. 275, 23491-23499.
2. Breitschopf, K., Bengal, E., Ziv, T., Admon, A., and Ciechanover, A. (1998). A novel site for ubiquitination: The N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J. 17, 5964-5973.
3. Busson, P., Edwards, R. H., Tursz, T., and Raab-Traub, N. (1995). Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J. Gen. Virol. 76, 139-145.
4. Caldwell, R. G., Brown, R. C., and Longnecker, R. (2000). Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J. Virol. 74, 1101-1113.
5. Caldwell, R. G., Wilson, J. B., Anderson, S. J., and Longnecker, R. (1998). Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405-411.
6. Chen, H., Smith, P., Ambinder, R. F., and Hayward, S. D. (1999). Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood 93, 3026-3032.
7. Driessen, H. P., de Jong, W. W., Tesser, G. I., and Bloemendal, H. (1985). The mechanism of N-terminal acetylation of proteins. Crit. Rev. Biochem. 18, 281-325.
8. Dykstra, M. L., Longnecker, R., and Pierce, S. K. (2001). Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 14, 57-67.
9. Franken, M., Annis, B., Ali, A. N., and Wang, F. (1995). 5′ Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio. J. Virol. 69, 8011-8019.
10. Freemont, P. S. (2000). RING for destruction? Curr. Biol. 10, R84-87.
11. Fruehling, S., Lee, S. K., Herrold, R., Frech, B., Laux, G., Kremmer, E., Grasser, F. A., and Longnecker, R. (1996). Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J. Virol. 70, 6216-6226.
12. Fruehling, S., and Longnecker, R. (1997). The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241-251.
13. Fruehling, S., Swart, R., Dolwick, K. M., Kremmer, E., and Longnecker, R. (1998). Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72, 7796-7806.
14. Harvey, K. F., and Kumar, S. (1999). Nedd4-like proteins: an emerging family of ubiquitin-protein ligases implicated in diverse cellular functions. Trends Cell Biol. 9, 166-169.
15. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
16. Huibregtse, J. M., Scheffner, M., Beaudenon, S., and Howley, P. M. (1995). A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase [published erratum appears in Proc. Natl. Acad. Sci. USA 92(11), 5249 (1995)]. Proc. Natl. Acad. Sci. USA 92, 2563-2567.
17. Ikeda, M., Ikeda, A., Longan, L. C., and Longnecker, R. (2000). The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology 268, 178-191.
18. Ikeda, M., Ikeda, A., and Longnecker, R. (2001). PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. J. Virol. 75, 5711-5718.
19. Kanelis, V., Rotin, D., and Forman-Kay, J. D. (2001). Solution structure of a Nedd4 WW domain-ENaC peptide complex. Nat. Struct. Biol. 8, 407-412.
20. Kieff, E. (1996). Epstein-Barr virus and its replication. In "Fundamental Virology" (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), pp. 1109-1162. Lippincott-Raven, Philadelphia, PA.
21. Kozak, M. (1986). Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283-292.
22. Longnecker, R. (1998). Molecular biology of Epstein-Barr virus. In "Human Tumor Viruses" (D. J. McCance, Ed.), pp. 133-172. American Society for Microbiology, Washington, D.C.
23. Longnecker, R., and Kieff, E. (1990). A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J. Virol. 64, 2319-2326.
24. Miller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B., and Kieff, E. (1995). Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155-166.
25. Miller, C. L., Longnecker, R., and Kieff, E. (1993). Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67, 3087-3094.
26. Reinstein, E., Scheffner, M., Oren, M., Ciechanover, A., and Schwartz, A. (2000). Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 19, 5944-5950.
27. Rivailler, P., Quink, C., and Wang, F. (1999). Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus. J. Virol. 73, 8867-8872.
28. Sample, J., Liebowitz, D., and Kieff, E. (1989). Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J. Virol. 63, 933-937.
29. Thorley-Lawson, D. A. (2001). Epstein-Barr virus: Exploiting the immune system. Nat. Rev. Immunol. 1, 75-82.
30. Treier, M., Staszewski, L. M., and Bohmann, D. (1994). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787-798.
31. Winberg, G., Matskova, L., Chen, F., Plant, P., Rotin, D., Gish, G., Ingham, R., Ernberg, I., and Pawson, T. (2000). Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol. Cell. Biol. 20, 8526-8535.